Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leef BrandsLEEEF +0.75%32 Cash-to-Debt is 0.40 as of Jun. 2026, which is 20% below its 10-year median of 0.50. GuruFocus rates LEEEF with a GF Score™ of 32/100 and a GF Value™ of $0.12 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 979 Drug Manufacturers companies, Leef Brands ranks worse than 65.88% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Leef Brands's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.40.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Leef Brandscouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Leef Brands's Cash-to-Debt or its related term are showing as below:
LEEEF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 0.5 Max: No Debt
Current: 0.4
During the past 13 years, Leef Brands's highest Cash to Debt Ratio was No Debt. The lowest was 0.04. And the median was 0.50.
LEEEF's Cash-to-Debt is ranked worse than 65.88% of 979
companies
in the Drug Manufacturers industry
Industry Median: 0.97
vs LEEEF: 0.40
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Leef Brands Cash-to-Debt Related Terms
Leef Brands Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Leef Brands's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands Cash-to-Debt vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Leef Brands's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a Cash-to-Debt of 0.40 as of Jun. 2026. This is 20% below median its historical median of 0.50. Over the past decade, Leef Brands' Cash-to-Debt has ranged from 0.04 to 10,000.00. According to the industry distribution chart, Leef Brands ranks #645 out of 979 companies in the Drug Manufacturers industry, placing it in the top 65.9%.
Is Leef Brands' Cash-to-Debt too high?
Leef Brands' current Cash-to-Debt of 0.40 is 20% below median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 10,000.00. The Drug Manufacturers industry median Cash-to-Debt is 0.97. Leef Brands' value of 0.40 is 58.8% below this industry median. Based on the distribution chart, Leef Brands ranks #645 out of 979 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Leef Brands has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' Cash-to-Debt compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #645 out of 979 companies for Cash-to-Debt. This places Leef Brands in the lower half of its industry. The industry median Cash-to-Debt is 0.97. Leef Brands' value of 0.40 is 58.8% below this benchmark. Historically, Leef Brands' own Cash-to-Debt has ranged from 0.04 to 10,000.00 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 0.97, Leef Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Drug Manufacturers company?
The median Cash-to-Debt among Drug Manufacturers companies is 0.97, based on 979 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current Cash-to-Debt of 0.40 is 58.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Cash-to-Debt is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current Cash-to-Debt is 0.40, which is 20% below median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.12, compared to a current price of $0.20 — trading 67.5% above its estimated fair value. The current Cash-to-Debt is 0.40, which is 20% below median its 10-year median of 0.50 and 58.8% below the Drug Manufacturers industry median of 0.97. Leef Brands' overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Leef Brands (LEEEF), the current Cash-to-Debt is 0.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.20 is trading 67.5% above its estimated GF Value™ of $0.12.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
Cash-to-Debt: 0.40 (20% below median its 10-year median of 0.50)
GF Value™: $0.12 vs. price of $0.20 (67.5% above fair value)
Industry Position: 58.8% below the Drug Manufacturers median (#645 of 979)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
32GF Score
Get the complete analysis for LEEEF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
